Department of Clinical Immunology and Transfusion Medicine, Karolinska University Lab, Stockholm, Sweden

Karolinska University Laboratory, Clinical Immunology and Transfusion medicine. This routine laboratory servers the hospital with all clinical tests needed, including, but not limited to, drug levels for infliximab, adalimumab, etanercept and rituximab as well as ADA for infliximab and adalimumab. An academic health care system including research and education is established with a close strategic partnership between Karolinska University Hospital and Karolinska Institutet.

Diseases Researched:

The main diseases that are tested in the lab are autoimmune and inflammatory diseases:

  • Inflammatory bowel disease
  • Rheumatoid arthritis
  • Systemic lupus erythematosus (SLE)
  • Psoriasis

Performed Tests:

Drug levels:

  • Measures adalimumab, infliximab, etanercept, rituximab, ustekinumab and vedolizumab with ELISA

ADA titres:

  • Measure ADA against infliximab and adalimumab with ELISA

Website link: